<scp>RNA</scp> toxicity induced by expanded <scp>CAG</scp> repeats in <scp>H</scp>untington's disease

Brain Pathology - Tập 26 Số 6 - Trang 779-786 - 2016
Eulàlia Martı́1,2,3,4
1Centre for Genomic Regulation (CRG), The Barcelona Institute for Science and Technology, Dr. Aiguader 88, Barcelona 08003, Spain
2Centro de Investigacion Biomedica en Red (CIBERESP) Madrid Spain
3Institut Hospital del Mar d'Investigacions Mediques (IMIM) Barcelona 08003 Spain
4Universitat Pompeu Fabra (UPF), Barcelona, Spain

Tóm tắt

AbstractHuntington's disease (HD) belongs to the group of inherited polyglutamine (PolyQ) diseases caused by an expanded CAG repeat in the coding region of the Huntingtin (HTT) gene that results in an elongated polyQ stretch. Abnormal function and aggregation of the mutant protein has been typically delineated as the main molecular cause underlying disease development. However, the most recent advances have revealed novel pathogenic pathways directly dependent on an RNA toxic gain‐of‐function. Expanded CAG repeats within exon 1 of the HTT mRNA induce toxicity through mechanisms involving, at least in part, gene expression perturbations. This has important implications not only for basic and translational research in HD, but also for other types of diseases carrying the expanded CAG in other genes, which likely share pathogenic aspects. Here I will review the evidence and mechanisms underlying RNA toxicity in CAG repeat expansions, with particular focus on HD. These comprise abnormal subcellular localization of the transcripts containing the expanded CAG repeats; sequestration of several types of proteins by the expanded CAG repeat which results in defects of alternative splicing events and gene expression; and aberrant biogenesis and detrimental activity of small CAG repeated RNAs (sCAG) that produce altered gene silencing. Although these altered pathways have been detected in HD models, their contribution to disease development and progress requires further study.

Từ khóa


Tài liệu tham khảo

10.1016/j.neuron.2005.06.005

10.1016/j.neuron.2015.10.038

10.1371/journal.pgen.1002481

10.1093/hmg/ddq132

10.1016/j.molcel.2004.06.012

Bowles KR, 2014, Kinase signalling in Huntington's disease, J Huntingtons Dis, 3, 89, 10.3233/JHD-140106

10.1111/gbb.12273

10.1038/nrn1806

10.1016/S1097-2765(02)00572-5

10.1093/nar/gkh818

10.1093/hmg/ddr263

10.1073/pnas.94.14.7388

10.1093/nar/gkq1323

10.1038/nrg1348

10.1093/nar/gkf483

10.1093/nar/29.13.2766

10.1038/nm.3617

10.1515/hsz-2012-0218

10.4161/rna.26706

10.1172/JCI70911

10.1038/sj.emboj.7600300

10.1038/70493

10.1371/journal.pone.0016417

10.1016/j.febslet.2004.03.109

10.1093/nar/gkg767

10.1093/hmg/ddh327

10.1111/j.1471-4159.2008.05316.x

10.1093/hmg/ddi223

10.1093/hmg/ddu492

10.1093/nar/gkq127

10.1016/j.molcel.2007.01.031

10.1093/nar/gkr729

10.1016/j.tibs.2013.05.003

10.1093/hmg/ddr292

10.1038/nature06909

10.1038/nrm2854

10.1093/nar/gkq575

10.1371/journal.pone.0137620

10.1093/emboj/19.17.4439

10.1038/ng1827

10.1093/nar/gkr608

10.1146/annurev.neuro.29.051605.113042

10.1073/pnas.0407004101

10.1523/JNEUROSCI.2439-08.2008

10.1126/science.280.5364.737

10.1093/nar/28.20.3943

10.4161/cc.20423

10.1093/hmg/2.9.1429

10.1523/JNEUROSCI.0590-10.2011

10.1073/pnas.1221891110

10.1073/pnas.0800658105

10.1038/ng704

10.1074/jbc.M405130200

10.1074/jbc.M409984200

10.1074/jbc.M109.078790

10.1038/srep12521

10.1093/jmcb/mjq005

10.1083/jcb.128.6.995

10.1101/gr.10.7.967

10.1007/s12311-012-0447-6

10.1016/j.bbadis.2013.11.015

10.1093/hmg/ddr297

10.1073/pnas.1204089109

10.1016/j.cell.2012.06.041

10.1007/s00018-010-0522-4

10.1073/pnas.1220068110

10.1016/j.neuron.2011.03.021

10.1146/annurev-biophys-083012-130404

10.1093/hmg/ddr299

10.1371/journal.pgen.1001340

10.1093/nar/gkm601

10.1074/jbc.M107598200

10.1073/pnas.1013343108